Invests in
Locations:
Min Investment:
$2,500,000.00Max Investment:
$15,000,000.00Target Investment:
$5,000,000.00
Skills
Education
- UA
- SU
Lists including Jeffrey
Work Experience
2023
Managing Partner
2023
Investing in the transformation of traditional industries through software, smart hardware and physical innovations. Pre-seed, seed, and Series A.
2020
Vice President, Materials Strategy & Partnerships
2020
In addition to having led the integration of Origin with Stratasys, I now lead the 3rd party materials strategy for Stratasys focused on the company's growth into the manufacturing market and all materials partnerships across all of Stratasys' technology platforms (DLP, FDM, SLA, SAF, PJ).
2019 - 2020
Chief Operating Officer
2019 - 2020
Led negotiations resulting in a $100M+ merger with Stratasys (Nasdaq: SSYS), the leading pure-play 3D printing company in the market. Origin is an additive manufacturing (3D printing) platform designed for mass production featuring an open materials network, extensible software, and modular hardware. See more at: www.origin.io I sourced DCM's investment in Origin to lead the company's $10M Series A financing round. After working with the team for more than a year, I joined Origin full time to truly bring additive to mass manufacturing.
2014 - 2019
Venture Partner
2014 - 2019
Focused on early stage technology investments and portfolio company management for companies in North America. DCM Ventures is an early-stage venture capital firm with $4 billion under management and a focus on North America, China and Japan. DCM has invested in about 300 technology companies with an enterprise value exceeding $100 billion. Board Member/Led Investments in: Mobileum (Board member, Acquisition by Audax), WePow (Board member, Acquired by Outmatch), Trion (Board Member, Acquired by Gamigo), AdSpace (board member), SirenCare (sourced), Origin (sourced), JackPocket (sourced), RayVio (board member, spun out LARQ), Athos (board member)
2018 - 2019
Board Observer
2018 - 2019
Jackpocket allows users to play lotteries such as PowerBall and Mega Millions on your phone through partnerships directly with the governing states. I met Pete (founder/CEO) 3 years prior, tracked the company, and recently invested in the company's $16M Series B financing. Sourced this investment opportunity for DCM.
2018 - 2019
Board Observer
2018 - 2019
Origin's modular 3D printing system and open materials network enables additive to revolutionize the $600B plastics manufacturing market. By enabling sophisticated partners like BASF to develop on Origin's platform, the company is able to bring cutting edge materials that cost 10x less that are needed for mass manufacturing. Sourced the opportunity, developed the relationship with the CEO, drove diligence and internal processes to lead the company's $10M Series A financing round.
2017 - 2019
Board Member
2017 - 2019
AdSpace owns and operates the largest digital advertising network in malls, with 95% of all malls covered reaching 650MM impressions and 71MM unique visitors monthly.
2017 - 2019
Board Member
2017 - 2019
RayVio’s advanced health and hygiene technology makes UV disinfection for water, air, and surfaces that is 100x more powerful and 5x cheaper than anything on the market. Successfully engineered the spinout of LARQ, a B2C consumer hydration brand focused on clean water.
2017 - 2019
Board Member
2017 - 2019
Athos’ smart clothing helps athletes train more effectively and reach their performance goals faster by measuring how muscles are being used through their unique fabric technology.
2017 - 2019
Seed Investor
2017 - 2019
Siren Care is building the next generation of smart textiles. The company's Neurofabric technology enables any type of micro-sensor to be inserted into fabrics without the user being able to feel wires or components, and has applications across healthcare, fashion, entertainment, fitness, and even the military. They company's first product, a connected Diabetic Sock, prevents millions of diabetic foot ulcers and tens of billions of dollars of associated medical expenses through always-on temperature monitoring. This has been clinically-proven to reduce the incidence of diabetic foot ulcers by 87%. Sourced and led the seed investment in the company. Co-investors include Khosla Ventures and Founders Fund.